Collagen Solutions : New contract with Desu Medical for the supply of soluble collagen

22 December 2014

Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that its subsidiary Collagen Solutions (UK) Limited has agreed a contract with Desu Medical to supply soluble collagen. This agreement is for the manufacturing of brain dura and spinal fusion implants which will be used in the treatment of dura/spinal injuries by stimulating enhanced dura/bone generation through the use of high concentration collagen. Dura is the thick membrane that surrounds and protects the brain and spinal cord.

Collagen Solutions is committed to providing the highest quality collagen-based biomaterials to support medical devices and regenerative medical interventions across a wide range of applications and clinical indications. The announcement confirms that its soluble collagen will be used in the production of Desu Medical's brain and spinal implants DECOLL® and DEBONE®.

Dr Stewart White, CEO of Collagen Solutions plc said: "We are pleased to announce that we have reached an agreement for the supply of our soluble collagen product to Desu Medical. This agreement is the culmination of a long association with Desu Medical during which we have been supplying developmental quantities of medical grade collagen. Winning this contract is based on our ability to convince such an established Company that we can supply a medical grade collagen suitable for manufacturing their products consistently and to order, for the life of the product line. It is important for companies to secure their source of the collagen early in the commercialisation process as this will become part of the regulatory submissions for their products around the World. The long term provision of our medical grade collagen for an increasing number of products begins to unlock the value that we have in our manufacturing capabilities."

Dr Mehmet Sorar, CEO of Desu Medical said: "We are equally pleased to announce our agreement with Collagen Solutions. Our aim is to make our products - DEBONE® and DECOLL®, which contain up to 90% soluble collagen - leading brands in the market. We hope that our collaboration will last for many years to come."

Enquiries:

distributed by